Assessment and reproducibility of aortic atherosclerosis magnetic resonance imaging: Impact of 3-tesla field strength and parallel imaging

Investigative Radiology

Volumn 43, Issue 9, 2008, Pages 656-662

  Maroules, Christopher D ^a   McColl, Roderick ^a   Khera, Amit ^a   Peshock, Ronald M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; MRI; Parallel imaging

Indexed keywords

ABDOMINAL AORTA; ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTRAST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIFFUSION WEIGHTED IMAGING; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; IMAGE QUALITY; MALE; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; WILCOXON SIGNED RANKS TEST; AORTA DISEASE; ATHEROSCLEROSIS; COMPUTER ASSISTED DIAGNOSIS; EVALUATION; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

AORTA, ABDOMINAL; AORTIC DISEASES; ATHEROSCLEROSIS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 55249127390     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318181538a     Document Type: Article

References (29)

1. Serfaty JM, Chaabane L, Tabib A, et al. Atherosclerotic plaques: classification and characterization with T2-weighted high-spatial-resolution MR imaging-an in vitro study. Radiology. 2001;219:403-410.
2. McMahan CA, Gidding SS, Fayad ZA, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med. 2005;165: 883-890.
3. Yuan C, Kerwin WS. MRI of atherosclerosis. J Magn Reson Imaging. 2004;19:710-719.
4. Koops A, Ittrich H, Petri S, et al. Multicontrast-weighted magnetic resonance imaging of atherosclerotic plaques at 3.0 and 1.5 Tesla: ex-vivo comparison with histopathologic correlation. Eur Radiol. 2007; 17:279-286.
5. Taniguchi H, Momiyama Y, Fayad ZA, et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J. 2004;148:137-143.
6. McGill HC Jr, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000;20:836-845.
7. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281:727-735.
8. Victor RG, Haley RW, Willett DL, et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93: 1473-1480.
9. Jaffer FA, O'Donnell CJ, Larson MG, et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2002;22:849-854.
10. Li AE, Kamel I, Rando F, et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR Am J Roentgenol. 2004; 182:593-597.
11. Simonetti OP, Finn JP, White RD, et al. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology. 1996; 199: 49-57.
12. Hinton DP, Wald LL, Pitts J, et al. Comparison of cardiac MRI on 1.5 and 3.0 Tesla clinical whole body systems. Invest Radiol. 2003;38:436-442.
13. Kramer H, Schoenberg SO, Nikolaou K, et al. Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005;236:300-310.
14. Pruessmann KP, Weiger M, Scheidegger MB, et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med. 1999;42:952-962.
15. Yarnykh VL, Terashima M, Hayes CE, et al. Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 Tesla magnetic field strengths. J Magn Reson Imaging. 2006;23:691-698.
16. Nael K, Ruehm SG, Michaely HJ, et al. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol. 2006;41:391-399.
17. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys. 1985;12:232-233.
18. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med. 2005;54:748-754.
19. Rosero EB, Timaran CH, Khera A, et al. Abdominal aortic wall-thickness by magnetic resonance imaging and cardiovascular disease in a multi-ethnic population-based study. Presented at: UT Southwestern Clinical Research Symposium 2007; April 2007.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
21. Quan H, Shih WJ. Assessing reproducibility by the within-subject coefficient of variation with random effects models. Biometrics. 1996; 52:1195-1203.
22. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29-34.
23. Kim WY, Astrup AS, Stuber M, et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation. 2007; 115: 228-235.
24. Chan SK, Jaffer FA, Botnar RM, et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J Cardiovasc Magn Reson. 2001;3:331-338.
25. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316: 1371-1375.
26. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005; 46:106-112.
27. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002; 106:2884-2887.
28. Helft G, Worthley SG, Fuster V, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002;105:993-998.
29. Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology. 2006;240:464-472.